Summary:
To address drug shortages and concerns about quality, industry experts say Congress should consider steps such as improving hospital incentives and revising purchasing contracts.
Mounting drug shortages and supply chain vulnerabilities are putting patient care at risk in hospitals across the nation. As experts sound the alarm in Congress, questions grow about the safety, cost, and reliability of vital medicines. What concrete steps can policymakers and industry leaders take to secure America’s pharmaceutical future? Read on to discover the proposals and debates shaping the path forward.
Source: Senate Committee Examines Ways to Strengthen the Supply Chain for Hospital Drugs, Nick Hut, HFMA, October 13,2025; https://www.hfma.org/operations-management/senate-committee-examines-ways-to-strengthen-the-supply-chain-for-hospital-drugs/ .
Topics
Quality Improvement
Healthcare Process
Environmental Influences
Related
Effect of Discontinuing the Administration of Supplementary Electrophysical Agents Before and After Physical Therapy in a Medical Institute’s Outpatient Rehabilitation ProgramWhy Brittle Bones Aren’t Just a Woman’s ProblemHHS Office for Civil Rights Settles Ransomware Cybersecurity Investigation under HIPAA Security Rule for $250,000Recommended Reading
Quality and Risk
Why Brittle Bones Aren’t Just a Woman’s Problem
Quality and Risk
HHS Office for Civil Rights Settles Ransomware Cybersecurity Investigation under HIPAA Security Rule for $250,000
Strategy and Innovation
As Sports Betting Explodes, States Try To Set Limits To Stop Gambling Addiction
Strategy and Innovation
A Data-Based Approach to Delegating
Strategy and Innovation
To Change Company Culture, Focus on Systems—Not Communication